20 results
8-K
EX-99.1
LYEL
Lyell Immunopharma, Inc.
7 Nov 23
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
4:08pm
for their many contributions that have helped advance our mission.”
With key infrastructure now in place and a maturing company focus, the company
8-K
EX-99.1
3ivahosb0p7
8 Nov 22
Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results
4:07pm
8-K
EX-99.1
m16poii11z8bskug5
6 Oct 22
Regulation FD Disclosure
4:37pm
8-K
EX-99.1
awrc5
10 May 22
Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights
4:14pm
10-K
o55sei0 mp53j55
29 Mar 22
Annual report
4:20pm
8-K
EX-99.1
rbguyyp9v0wkye9
30 Sep 21
Departure of Directors or Certain Officers
4:05pm
10-Q
c9544n
12 Aug 21
Quarterly report
5:07pm
424B4
2h8tcnjbx8 6ozu17d
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
le5hs jganoui
9 Jun 21
IPO registration (amended)
7:12am
S-1
82h5r5w7i0 y8vpcxz
25 May 21
IPO registration
5:28pm
DRS/A
nvnqjc qw5x
12 May 21
Draft registration statement (amended)
12:00am
DRS
asmlc
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next